Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| argenx SEADR(ARGX) | 400,000 | 365,000 | -35,000 | $172.02M | $197.86M | 6.32% | +$25.84M |
| Dynavax Technologies Corp | 10,900,000 | 12,526,486 | +1,626,486 | $122.41M | $139.55M | 4.46% | +$17.14M |
| Guardant Health, Inc.(GH) | 4,500,000 | 6,000,560 | +1,500,560 | $129.96M | $137.65M | 4.39% | +$7.69M |
| Apellis Pharmaceuticals Inc COM | 2,500,000 | 4,400,654 | +1,900,654 | $95.90M | $126.91M | 4.05% | +$31.01M |
| Immunovant, Inc.(IMVT) | 2,883,736 | 4,347,464 | +1,463,728 | $76.13M | $123.95M | 3.96% | +$47.82M |
| Springworks Therapeutics Inc | 3,700,000 | 3,843,900 | +143,900 | $139.38M | $123.16M | 3.93% | -$16.22M |
| Dyne Therapeutics, Inc.(DYN) | 4,000,000 | 3,282,000 | -718,000 | $141.16M | $117.89M | 3.76% | -$23.27M |
| Intra-Cellular Therapies Inc | 1,537,922 | 1,600,693 | +62,771 | $105.33M | $117.12M | 3.74% | +$11.79M |
| Ocular Therapeutix, Inc.(OCUL) | 12,721,460 | 12,721,460 | 0 | $87.01M | $110.68M | 3.53% | +$23.66M |
| Intellia Therapeutics, Inc.(NTLA) | 4,800,000 | 4,950,000 | +150,000 | $107.42M | $101.72M | 3.25% | -$5.70M |
| Alkermes plcSHS(ALKS) | 3,500,000 | 3,500,000 | 0 | $84.35M | $97.97M | 3.13% | +$13.62M |
| Verona Pharma PlcADS | 4,000,000 | 3,180,025 | -819,975 | $57.84M | $91.49M | 2.92% | +$33.65M |
| Ionis Pharmaceuticals, Inc.(IONS) | 2,000,000 | 2,200,000 | +200,000 | $95.32M | $88.13M | 2.81% | -$7.19M |
| Nurix Therapeutics, Inc.(NRIX) | 3,991,500 | 3,868,104 | -123,396 | $83.30M | $86.92M | 2.77% | +$3.61M |
| Viridian Therapeutics, Inc.(VRDN) | 3,923,849 | 3,750,945 | -172,904 | $51.05M | $85.33M | 2.72% | +$34.28M |
| Bicycle Therapeutics PlcADS | 3,490,506 | 3,548,001 | +57,495 | $70.65M | $80.29M | 2.56% | +$9.64M |
| MBX Biosciences, Inc.(MBX) | 0 | 3,018,935 | +3,018,935 | $0 | $78.43M | 2.50% | +$78.43M |
| Axsome Therapeutics, Inc.(AXSM) | 1,852,784 | 857,219 | -995,565 | $149.15M | $77.04M | 2.46% | -$72.11M |
| Pliant Therapeutics, Inc.(PLRX) | 5,972,257 | 5,972,257 | 0 | $64.20M | $66.95M | 2.14% | +$2.75M |
| Apogee Therapeutics Inc | 1,000,000 | 1,000,000 | 0 | $39.35M | $58.74M | 1.88% | +$19.39M |
| Autolus Therapeutics plcADS(AUTL) | 15,272,172 | 15,272,172 | 0 | $53.15M | $55.44M | 1.77% | +$2.29M |
| Structure Therapeutics IncADS | 950,000 | 1,220,508 | +270,508 | $37.31M | $53.57M | 1.71% | +$16.26M |
| Olema Pharmaceuticals, Inc.(OLMA) | 4,000,000 | 4,000,000 | 0 | $43.28M | $47.76M | 1.52% | +$4.48M |
| Terns Pharmaceuticals Inc | 6,100,000 | 5,576,558 | -523,442 | $41.54M | $46.51M | 1.48% | +$4.97M |
| 4d Molecular Therapeutics In | 4,061,401 | 4,096,452 | +35,051 | $85.25M | $44.28M | 1.41% | -$40.97M |
| ABIVAX Société AnonymeADS(ABVX) | 4,179,763 | 3,579,209 | -600,554 | $55.26M | $41.23M | 1.32% | -$14.02M |
| TG Therapeutics, Inc.(TGTX) | 2,870,131 | 1,725,000 | -1,145,131 | $51.06M | $40.35M | 1.29% | -$10.71M |
| Mind Medicine Mindmed Inc | 6,103,817 | 7,065,099 | +961,282 | $44.01M | $40.20M | 1.28% | -$3.81M |
| Kura Oncology, Inc.(KURA) | 384,756 | 1,963,505 | +1,578,749 | $7.92M | $38.37M | 1.22% | +$30.44M |
| Geron Corporation(GERN) | 13,000,000 | 7,575,049 | -5,424,951 | $55.12M | $34.39M | 1.10% | -$20.73M |
| Cytokinetics, Incorporated(CYTK) | 132,495 | 629,906 | +497,411 | $7.18M | $33.26M | 1.06% | +$26.08M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 1,235,187 | +1,235,187 | $0 | $30.27M | 0.97% | +$30.27M |
| ANI Pharmaceuticals, Inc.(ANIP) | 466,089 | 504,828 | +38,739 | $29.68M | $30.12M | 0.96% | +$437.5K |
| Spyre Therapeutics, Inc.(SYRE) | 1,756,667 | 1,000,000 | -756,667 | $41.30M | $29.41M | 0.94% | -$11.89M |
| Edgewise Therapeutics, Inc.(EWTX) | 186,386 | 1,100,536 | +914,150 | $3.36M | $29.37M | 0.94% | +$26.02M |
| Kymera Therapeutics, Inc.(KYMR) | 1,500,000 | 600,326 | -899,674 | $44.77M | $28.41M | 0.91% | -$16.36M |
| Korro Bio, Inc.(KRRO) | 770,645 | 850,000 | +79,355 | $26.10M | $28.41M | 0.91% | +$2.31M |
| Avidity Biosciences Inc | 0 | 475,000 | +475,000 | $0 | $21.82M | 0.70% | +$21.82M |
| Centessa Pharmaceuticals PlcADS | 0 | 1,350,000 | +1,350,000 | $0 | $21.59M | 0.69% | +$21.59M |
| Alector Inc | 4,631,998 | 4,631,998 | 0 | $21.03M | $21.59M | 0.69% | +$555.8K |
| Nektar Therapeutics(NKTR) | 17,875,498 | 15,922,655 | -1,952,843 | $22.17M | $20.70M | 0.66% | -$1.47M |
| 89bio Inc | 2,294,011 | 2,766,512 | +472,501 | $18.38M | $20.47M | 0.65% | +$2.10M |
| Bicara Therapeutics Inc | 0 | 796,852 | +796,852 | $0 | $20.30M | 0.65% | +$20.30M |
| Akero Therapeutics Inc | 0 | 689,784 | +689,784 | $0 | $19.79M | 0.63% | +$19.79M |
| Fate Therapeutics, Inc.(FATE) | 5,572,607 | 5,572,607 | 0 | $18.28M | $19.50M | 0.62% | +$1.23M |
| Silence Therapeutics plcADS(SLN) | 1,359,745 | 1,000,000 | -359,745 | $25.84M | $18.18M | 0.58% | -$7.66M |
| Engene Holdings Inc COM | 2,250,000 | 2,607,633 | +357,633 | $21.22M | $17.21M | 0.55% | -$4.01M |
| Editas Medicine, Inc.(EDIT) | 6,000,000 | 4,900,334 | -1,099,666 | $28.02M | $16.71M | 0.53% | -$11.31M |
| Xencor, Inc.(XNCR) | 0 | 800,000 | +800,000 | $0 | $16.09M | 0.51% | +$16.09M |
| Pyxis Oncology, Inc.(PYXS) | 4,184,100 | 4,184,100 | 0 | $13.85M | $15.36M | 0.49% | +$1.51M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $14.88M | $14.54M | 0.46% | -$333.9K |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 1,529,987 | +1,529,987 | $0 | $13.60M | 0.43% | +$13.60M |
| Zura Bio LimitedCL A(ZURA) | 3,283,783 | 3,283,783 | 0 | $11.49M | $13.33M | 0.43% | +$1.84M |
| Invivyd, Inc.(IVVD) | 10,953,937 | 10,953,937 | 0 | $12.05M | $11.17M | 0.36% | -$876.3K |
| Climb Bio, Inc.(CLYM) | 3,904,785 | 2,169,143 | -1,735,642 | $27.76M | $11.04M | 0.35% | -$16.72M |
| Inovio Pharmaceuticals, Inc.(INO) | 2,066,720 | 1,804,366 | -262,354 | $16.70M | $10.43M | 0.33% | -$6.27M |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 967,000 | +967,000 | $0 | $9.19M | 0.29% | +$9.19M |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 567,428 | +567,428 | $0 | $7.50M | 0.24% | +$7.50M |
| Travere Therapeutics, Inc.(TVTX) | 7,370,000 | 531,857 | -6,838,143 | $60.58M | $7.44M | 0.24% | -$53.14M |
| Vigil Neuroscience Inc | 597,215 | 1,553,996 | +956,781 | $2.39M | $5.28M | 0.17% | +$2.89M |
| Regulus Therapeutics Inc | 3,262,564 | 3,262,564 | 0 | $5.82M | $5.12M | 0.16% | -$701.5K |
| Allakos Inc | 5,000,000 | 5,000,000 | 0 | $5.00M | $3.27M | 0.10% | -$1.73M |
| Alto Neuroscience, Inc.(ANRO) | 511,686 | 219,648 | -292,038 | $5.47M | $2.51M | 0.08% | -$2.96M |
| Prothena Corp PlcSHS SHS | 0 | 140,000 | +140,000 | $0 | $2.34M | 0.07% | +$2.34M |
| Relmada Therapeutics, Inc.(RLMD) | 1,234,773 | 674,833 | -559,940 | $3.70M | $2.19M | 0.07% | -$1.52M |
| Aligos Therapeutics, Inc.(ALGS) | 0 | 244,110 | +244,110 | $0 | $2.11M | 0.07% | +$2.11M |
| Syros Pharmaceuticals Inc | 828,485 | 828,485 | 0 | $4.27M | $1.78M | 0.06% | -$2.49M |
| Metagenomi Therapeutics, Inc.(MGX) | 466,232 | 307,500 | -158,732 | $1.90M | $667.3K | 0.02% | -$1.23M |
| Scholar Rock Holding Corporation(SRRK) | 372,559 | 48,100 | -324,459 | $3.10M | $385.3K | 0.01% | -$2.72M |
| Agenus Inc.(AGEN) | 313,359 | 0 | -313,359 | $5.25M | $0 | — | -$5.25M |
| Aligos Therapeutics Inc | 6,102,770 | 0 | -6,102,770 | $2.14M | $0 | — | -$2.14M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 500,000 | 0 | -500,000 | $121.50M | $0 | — | -$121.50M |
| Amgen Inc.(AMGN) | 575,000 | 0 | -575,000 | $179.66M | $0 | — | -$179.66M |
| Cogent Biosciences, Inc.(COGT) | 308,235 | 0 | -308,235 | $2.60M | $0 | — | -$2.60M |
| Cybin D/B/A Helus Pharma(HELP) | 58,139,535 | 0 | -58,139,535 | $15.76M | $0 | — | -$15.76M |
| Hillevax Inc | 1,832,652 | 0 | -1,832,652 | $26.50M | $0 | — | -$26.50M |
| Insmed Incorporated(INSM) | 2,000,000 | 0 | -2,000,000 | $134.00M | $0 | — | -$134.00M |
| Praxis Precision Medicines, Inc.(PRAX) | 389,546 | 0 | -389,546 | $16.11M | $0 | — | -$16.11M |
| Repare Therapeutics Inc | 904,261 | 0 | -904,261 | $2.98M | $0 | — | -$2.98M |